Bio-Hermes-002 is the unique, observational platform study that compares blood-based and digital biomarkers across a broad range of clinical cognitive conditions, MRI and PET images as well as ...

BREA, Calif. & TOKYO--(BUSINESS WIRE)--Beckman Coulter Diagnostics, a clinical diagnostics leader, and Fujirebio, a leader in neurological markers and In Vitro Diagnostic (IVD) manufacturing, today ...

BREA, Calif. & TOKYO--(BUSINESS WIRE)--Beckman Coulter Diagnostics, a clinical diagnostics leader, and Fujirebio, a leader in neurological markers and In Vitro Diagnostic (IVD) manufacturing, today ...

BREA, Calif., July 25, 2024 /PRNewswire/ -- Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the DxI 9000 Immunoassay Analyzer* was honored during Premier, Inc.'s ...

The collaboration aims to identify and develop accessible, minimally invasive blood-based biomarkers specific for tau pathology in the brain These tools have the potential to be used to stratify ...

(RTTNews) - Beckman Coulter Diagnostics, the clinical diagnostics unit of science and technology firm Danaher Corp. (DHR), announced Monday that the new DxC 500i Clinical Analyzer received 510(k) ...

Beckman Coulter, Inc. (NYSE: BEC), a leading developer, manufacturer, and marketer of products that simplify, automate, and innovate complex biomedical testing, today announced a record contract with ...

Beckman Coulter Diagnostics and COPAN have announced that Beckman Coulter Diagnostics and COPAN Group have entered into an amendment to their distribution agreement that expands their relationship ...

Beckman Coulter, a clinical diagnostics leader, today announced the launch of its Access SARS-CoV-2 Immunoglobulin M (IgM) assay in countries accepting the CE Mark. The new IgM antibody test ...

Beckman Coulter Diagnostics and Seegene Inc. have announced a Molecular Diagnostic assay supply agreement. Under the agreement, Seegene will begin manufacturing reagents designed exclusively for ...

- Beckman Coulter to take over distribution to customers of a B-type Natriuretic Peptide (BNP) assay, a marker of congestive heart failure on the company's immunoassay platforms - This BNP assay for ...

BREA, Calif., Sept. 10, 2025 /PRNewswire/ -- Beckman Coulter Diagnostics, a Danaher company and a leader in global clinical diagnostics innovation, today launched the industry's first fully automated ...